Literature DB >> 21160775

Clinical value of F-FDG PET/CT in assessing suspicious relapse after rectal cancer resection.

Long Sun1, Yong-Song Guan, Wei-Min Pan, Zuo-Ming Luo, Ji-Hong Wei, Long Zhao, Hua Wu.   

Abstract

AIM: To evaluate the value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in the restaging of resected rectal cancer.
METHODS: From January 2007 to Sep 2008, 21 patients who had undergone curative surgery resection for rectal carcinoma with suspicious relapse in conventional imaging or clinical findings were retrospectively enrolled in our study. The patients underwent 28 PET/CT scans (two patients had two scans, one patient had three and one had four scans). Locoregional recurrences and/or distant metastases were confirmed by histological analysis or clinical and imaging follow-up.
RESULTS: Final diagnosis was confirmed by histopathological diagnosis in 12 patients (57.1%) and by clinical and imaging follow-up in nine patients (42.9%). Eight patients had extrapelvic metastases with no evidence of pelvic recurrence. Seven patients had both pelvic recurrence and extrapelvic metastases, and two patients had pelvic recurrence only. (18)F-FDG PET/CT was negative in two patients and positive in 19 patients. (18)F-FDG PET/CT was true positive in 17 patients and false positive in two. The accuracy of (18)F-FDG PET/CT was 90.5%, negative predictive value was 100%, and positive predictive value was 89.5%. Five patients with perirectal recurrence underwent (18)F-FDG PET/CT image guided tissue core biopsy. (18)F-FDG PET/CT also guided surgical resection of pulmonary metastases in three patients and monitored the response to salvage chemotherapy and/or radiotherapy in four patients.
CONCLUSION: (18)F-FDG PET/CT is useful for evaluating suspicious locoregional recurrence and distant metastases in the restaging of rectal cancer after curative resection.

Entities:  

Keywords:  18F-fluorodeoxyglucose; Distant metastases; Follow-up; Locoregional recurrence; Positron emission tomography/computed tomography; Rectal cancer; Restaging

Year:  2009        PMID: 21160775      PMCID: PMC2999093          DOI: 10.4251/wjgo.v1.i1.55

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  36 in total

1.  Molecular imaging in cancer.

Authors:  Ralph Weissleder
Journal:  Science       Date:  2006-05-26       Impact factor: 47.728

2.  Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer?

Authors:  B J Robinson; T W Rice; S A Strong; L A Rybicki; E H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  1999-01       Impact factor: 5.209

Review 3.  Surgical adjuvant therapy for colorectal cancer: current approaches and future directions.

Authors:  Dulabh K Monga; Michael J O'Connell
Journal:  Ann Surg Oncol       Date:  2006-07-29       Impact factor: 5.344

4.  Local recurrence after mesorectal excision for rectal cancer.

Authors:  A Nesbakken; K Nygaard; O Westerheim; T Mala; O C Lunde
Journal:  Eur J Surg Oncol       Date:  2002-03       Impact factor: 4.424

5.  Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations.

Authors:  Dushyant V Sahani; Sanjeeva P Kalva; Leena M Hamberg; Peter F Hahn; Christopher G Willett; Sanjay Saini; Peter R Mueller; Ting-Yim Lee
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

6.  Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.

Authors:  Long Sun; Xin-Hui Su; Yong-Song Guan; Wei-Ming Pan; Zuo-Ming Luo; Ji-Hong Wei; Hua Wu
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

7.  Epidermal growth factor receptor antibody plus recombinant human endostatin in treatment of hepatic metastases after remnant gastric cancer resection.

Authors:  Long Sun; Huang-Yang Ye; Ying-Hong Zhang; Yong-Song Guan; Hua Wu
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

Review 8.  Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignancies.

Authors:  Long Sun; Hua Wu; Yong-Song Guan
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

9.  Computed tomography-guided core-needle biopsy specimens demonstrate epidermal growth factor receptor mutations in patients with non-small-cell lung cancer.

Authors:  C-M Chen; J W-C Chang; Y-C Cheung; G Lin; J-J Hsieh; T Hsu; S-F Huang
Journal:  Acta Radiol       Date:  2008-11       Impact factor: 1.990

10.  Colorectal cancer in Korea: characteristics and trends.

Authors:  Dong-Wan Kim; Yung-Jue Bang; Dae Seog Heo; Noe Kyeong Kim
Journal:  Tumori       Date:  2002 Jul-Aug
View more
  2 in total

1.  Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Yong-Liang Lu; Gai-Ling Li; Hui-Lian Huang; Jing Zhong; Li-Cheng Dai
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

2.  Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up 18F-FDG PET/CT Scans in Oncology Patients.

Authors:  Mehdi Taghipour; Charles Marcus; Sara Sheikhbahaei; Esther Mena; Shwetha Prasad; Abhinav K Jha; Lilja Solnes; Rathan M Subramaniam
Journal:  J Nucl Med       Date:  2016-11-03       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.